Laparoscopic sleeve gastrectomy with endoscopic guidance in morbid obesity

被引:18
作者
Frezza, Eldo E. [1 ]
Barton, Audrae [1 ]
Herbert, Haleigh
Wachtel, Mitchell S. [2 ]
机构
[1] Texas Tech Univ Hlth Sci Ctr, Dept Surg, Div Gen Surg, Lubbock, TX 79415 USA
[2] Texas Tech Univ Hlth Sci Ctr, Dept Pathol, Lubbock, TX 79415 USA
关键词
Laparoscopic sleeve gastrectomy; Upper endoscopy; Ghrelin; Weight loss; Bougie; Morbid obesity; Glucagon-like peptide 1; Stapler reinforcement;
D O I
10.1016/j.soard.2007.12.013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Sleeve gastrectomy (SG) has been shown to be an effective first-stage procedure for morbidly obese patients. The SG is presently performed over a bougie varying sizes, which is useful, but known to produce injuries on insertion. In a retrospective study, we evaluated the effect of the laparoscopic SG (LSG) on excess weight loss during 1 year of follow-up using a 29F endoscope instead of a bougie. Methods: During a 1-year period, LSG was performed on 20 (18 women and 2 men) consecutive patients. Gamma regression analysis was used to determine whether the variation in gender, age, initial body mass index, Hispanic ethnicity, and interval after surgery were related to excess weight loss. Results: No deaths and 1 minor complication of oozing from the staple line occurred. The excess weight loss increased steadily over time, with a median 20% at 3 months, 32% at 6 months, 42% at 9 months, and 53% at 12 months. The median initial body mass index was 44.5 kg/m(2), and the median age was 50 years. Of the 20 patients, 2 were men (10%) and 18 women (90%); 5 (25%) were Hispanic and 15 (75%) were non-Hispanic. The patients had a median 11.5 co-morbidities. Nausea was common for about 7 days postoperatively. An increase in the initial body mass index and increased co-morbidities were the only, 2 variables directly and statistically connected with the percentage of excess weight loss (P <.05). Conclusion: The results of our study have shown that LSG with endoscopic guidance appears safe and effective and could be tried using a larger set of patients as a single-stage operation. (Surg Obes Relat Dis 2008:4:575-580.) (c) 2008 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 28 条
[1]   Longitudinal gastrectomy as a treatment for the high-risk super-obese patient [J].
Almogy, G ;
Crookes, PF ;
Anthone, GJ .
OBESITY SURGERY, 2004, 14 (04) :492-497
[2]  
[Anonymous], 2006, R LANG ENV STAT COMP
[3]   Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans [J].
Ariyasu, H ;
Takaya, K ;
Tagami, T ;
Ogawa, Y ;
Hosoda, K ;
Akamizu, T ;
Suda, M ;
Koh, T ;
Natsui, K ;
Toyooka, S ;
Shirakami, G ;
Usui, T ;
Shimatsu, A ;
Doi, K ;
Hosoda, H ;
Kojima, M ;
Kangawa, K ;
Nakao, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) :4753-4758
[4]   Changes in insulin resistance following bariatric surgery and the adipoinsular axis: Role of the adipocytokines, leptin, adiponectin and resistin [J].
Ballantyne, GH ;
Gumbs, A ;
Modlin, IM .
OBESITY SURGERY, 2005, 15 (05) :692-699
[5]   Decreased bleeding after laparoscopic sleeve gastrectomy with or without duodenal switch for morbid obesity using a stapled buttressed absorbable polymer membrane [J].
Consten, ECJ ;
Gagner, M ;
Pomp, A ;
Inabnet, WB .
OBESITY SURGERY, 2004, 14 (10) :1360-1366
[6]   Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity [J].
Cottam, D. ;
Qureshi, F. G. ;
Mattar, S. G. ;
Sharma, S. ;
Holover, S. ;
Bonanomi, G. ;
Ramanathan, R. ;
Schauer, P. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2006, 20 (06) :859-863
[7]  
Edelman D S, 1998, JSLS, V2, P31
[8]   Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success? [J].
Frezza, EE .
OBESITY SURGERY, 2004, 14 (07) :999-1005
[9]  
FREZZA EE, SURG TODAY IN PRESS
[10]  
FREZZA EE, 2006, OBES RES, V14, P1